The group's principal activity is to own and operate stereotactic radiosurgery centers, utilizing the gamma knife technology. The gamma knife is a radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery. The group owns and operates two gamma knife centers in Kansas city and New York. The group's target market is medical centers in major health care catchment areas that have physicians experienced with and dedicated to use gamma knife.
